Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. Their lead pipeline candidates target commercially validated pathways and are designed through the ATTOBODY biologics platform to deliver improved treatments relative to the current standards of care.